Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Estrella M, Levy"'
Publikováno v:
Breast, Vol 60, Iss , Pp 15-25 (2021)
The clinical outcome of patients with human epidermal growth factor receptor 2 (HER2) amplified breast carcinoma (BC) has improved with the development of anti-HER2 targeted therapies. However, patients can experience disease recurrence after curativ
Externí odkaz:
https://doaj.org/article/e9a4b367e156407797f9a9931fef609d
Autor:
María B. Bordignon, Ayelén I. Pesce Viglietti, Estefanía P. Juliá, María B. Sanchez, Alexander Rölle, Pablo Mandó, Luciana Sabatini, Alexis Ostinelli, Manglio M. Rizzo, María M. Barrio, José Mordoh, Leonardo Fainboim, Estrella M. Levy
Publikováno v:
Cancer Immunology, Immunotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a7e4bd8e9cbe19e5f180a494450a501
https://doi.org/10.1007/s00262-023-03448-w
https://doi.org/10.1007/s00262-023-03448-w
Autor:
María B. Pampena, Holliday C. Cartar, Gerardo Rubén Cueto, Estrella M. Levy, Paula A. Blanco, María M. Barrio, José Mordoh
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
As cutaneous melanoma (CM) currently remains with a bleak prognosis, thorough investigation of new treatment options are of utmost relevance. In the phase II/III randomized clinical trial (CASVAC-0401), the repeated immunization of stages IIB-III CM
Externí odkaz:
https://doaj.org/article/d0202bd2edeb4b3683f56212be78feb8
Autor:
Estrella M Levy, Patricia Granados, Vanesa Rawe, Santiago Brugo Olmedo, María C Luna, Eduardo Cafferata, Omar H Pivetta
Publikováno v:
Medicina (Buenos Aires), Vol 64, Iss 3, Pp 213-218 (2004)
Congenital bilateral absence of the vas deferens (CBAVD) is a form of male infertility in which mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been identified. Here we identify different mutations of CFTR and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::c0f89481d8d3cd0e542594a78a0418ea
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802004000300004
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802004000300004
Autor:
María P, Roberti, Estefanía P, Juliá, Yamila S, Rocca, Mora, Amat, Alicia I, Bravo, José, Loza, Federico, Coló, Carlos M, Loza, Verónica, Fabiano, Mercedes, Maino, Ariel, Podhorzer, Leonardo, Fainboim, María M, Barrio, José, Mordoh, Estrella M, Levy
Publikováno v:
European journal of immunology. 45(5)
Clinical studies suggest that triple negative breast cancer (TNBC) patients with epidermal growth factor receptor (EGFR)-expressing tumors could benefit from therapy with Cetuximab, which targets EGFR. NK cells are the primary effectors of antibody (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eebd7d377831f1b7b027503974e4c3f5
https://pubmed.ncbi.nlm.nih.gov/25726929
https://pubmed.ncbi.nlm.nih.gov/25726929